Home › Funds › FRONTIER CAPITAL MANAGEMENT CO LLC › UTHR

FRONTIER CAPITAL MANAGEMENT CO LLC position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

FRONTIER CAPITAL MANAGEMENT CO LLC reported holding 206,808 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$112.1M, representing 1.04% of its reported portfolio and ranking #10 among its reported holdings. FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed UTHR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)206.81K sh
Reported value held$112.05M
Portfolio Weight1.04%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FRONTIER CAPITAL MANAGEMENT CO LLC's UTHR position evolved

FRONTIER CAPITAL MANAGEMENT CO LLC first disclosed a stake in UTHR in Q3 2023 at 33,764 shares (US$7.6M). The position peaked in Q1 2026 at 252,702 shares, worth US$149.8M. Across 12 filings, FRONTIER CAPITAL MANAGEMENT CO LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 206,808 shares valued at US$112.1M — a reduction of -45,894 shares quarter over quarter.. Notable position changes include a 376% increase in Q3 2024 (shares fell 2% over the following quarter), a 37% trim in Q2 2025 (shares rose 46% over the following quarter), a 39% increase in Q1 2026 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 33.76K $7.63M New
Q4 2023 33.80K $7.43M Hold
Q1 2024 33.04K $7.59M Reduce
Q2 2024 37.64K $11.99M Add
Q3 2024 179.15K $64.20M Add
Q4 2024 243.68K $85.98M Add
Q1 2025 313.82K $96.74M Add
Q2 2025 198.58K $57.06M Reduce
Q3 2025 173.95K $72.92M Reduce
Q4 2025 181.18K $88.28M Add
Q1 2026 252.70K $149.85M Add
Q2 2026 206.81K $112.05M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has FRONTIER CAPITAL MANAGEMENT CO LLC held UTHR?

FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed UTHR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is FRONTIER CAPITAL MANAGEMENT CO LLC's current position in UTHR?

As of Q2 2026, FRONTIER CAPITAL MANAGEMENT CO LLC holds 206.81K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $112.05M, representing 1.04% of its reported portfolio and ranking #10.

Has FRONTIER CAPITAL MANAGEMENT CO LLC been buying or selling UTHR?

In the latest 13F filing (Q2 2026), FRONTIER CAPITAL MANAGEMENT CO LLC reduced its position in UTHR. The position peaked in Q1 2026 at 252.70K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.